24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Emendo
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:20
The World Cup warning: Riots don’t start in the streets. They start online
18:07
“There’s a price where you have to say yes”: CyberArk founder on the $25 billion Palo Alto deal
14:18
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
13:32
“There is no better solution for Zim than the one we created”
More stories
Buzz
Most popular
Daily
Weekly
1
"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"
2
Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat
3
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
4
Echo: “Employees have become very good at identifying performative culture”
5
Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR
More news
Emendo
3 stories about Emendo
AnGes laying off 110 EmendoBio employees three years after $250 million acquisition
20.12.23
|
Meir Orbach
The Japanese pharma company notified the employees of the Israeli firm that they are being fired and the future of the company's technology is unclear at this point
“Innovation and groundbreaking innovation is really mind blowing. … That’s what inspires me today.”
31.08.21
|
CTech
Rachel Diamant, chief IP officer & head of pipeline development at Emendo Biotherapeutics joins Michael Matias to discuss biology and innovation
Gene Therapy Company Emendo Biotherapeutics Raises $61 Million
16.01.20
|
Adi Pick
Emendo uses protein engineering to treat certain genetic disorders and diseases